142
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia

, &
Pages 6225-6235 | Received 16 Jun 2023, Accepted 31 Aug 2023, Published online: 15 Sep 2023

References

  • Mckeage K, Keating GM. Tigecycline. Drugs. 2008;68(18):2633–2644. doi:10.2165/0003495-200868180-00008
  • Giamarellou H, Poulakou G. Pharmacokinetic and pharmacodynamics evaluation of tigecycline. Expert Opin Drug Metab Toxicol. 2011;7(11):1459–1470. doi:10.1517/17425255.2011.623126
  • Kasbekar N. Tigecycline: a critical safety review. Expert Opin Drug Saf. 2015;14(2):335–342. doi:10.2146/ajhp050487
  • Peterson LR. A review of tigecycline--the first glycylcycline. Int J Antimicrob Agents. 2008;32(Suppl 4):S215–22. doi:10.1016/S0924-8579(09)70005-6
  • Giryes S, Azzam ZS, Reem IB, Norberto K, Gidon B. Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline - Case Report and Review of Literature. Curr Drug Saf. 2017;12(1):7–9. doi:10.2174/1574886311666160920090714
  • Guo M, Liang J, Li D. Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database. Thromb J. 2022;20(1):12.
  • NIH. Common Terminology Criteria for Adverse Events.CTCAE. v6.0; 2020. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed December 19, 2022.
  • Kam T, Alexander M. Drug-induced immune thrombocytopenia. Drug Saf. 2004;27(15):1243–1252. doi:10.2165/00002018-200427150-00007
  • Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 Update of clinical and laboratory data. Am J Hematol. 2019;94(3):E76–E78. doi:10.1002/ajh.25379
  • Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–587. doi:10.1177/0897190014546099
  • Loo AS, Gerzenshtein L, Ison MG. Antimicrobial drug-induced thrombocytopenia: a review of the literature. Semin Thromb Hemost. 2012;38(8):818–829. doi:10.1055/s-0032-1328882
  • FDA Label. TYGACIL; 2020. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021821s049lbl.pdf. Accessed December 19, 2022.
  • Josefsdottir KS, Baldridge MT, Kadmon CS, King KY. Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. Blood. 2017;129(6):729–739. doi:10.1182/blood-2016-03-708594
  • Lassandro G, Palladino V, Palmieri VV, Amoruso A, Del Vecchio GC, Giordano P. Covid-19 and Children with Immune Thrombocytopenia: emerging Issues. Mediterr J Hematol Infect Dis. 2020;12(1):e2020028. doi:10.4084/MJHID.2020.028
  • Babinchak T, Ellis-Grosse E, Dartois N, Gilbert MR, Evan L; Tigecycline 301 Study Group, Tigecycline 306 Study Group. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005;41(Suppl 5):S354–67. doi:10.1086/431676
  • Hanai Y, Matsuo K, Ogawa M, et al. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia. J Infect Chemother. 2016;22(8):536–542. doi:10.1016/j.jiac.2016.05.003
  • Hu J, Xiao YH, Zheng Y, Lai YX, Fang XL, Fang Q. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients. Eur J Clin Pharmacol. 2020;76(7):913–922. doi:10.1007/s00228-020-02860-w
  • Hoffmann M, DeMaio W, Jordan RA, et al. Metabolism, excretion, and pharmacokinetics of [14C] tigecycline, a firstin-class glycylcycline antibiotic after intravenous infusion to healthy male subjects. Drug Metab Dispos. 2007;35:1543–1553. doi:10.1124/dmd.107.015735
  • Yaghoubi S, Zekiy AO, Krutova M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41(7):1003–1022. doi:10.1007/s10096-020-04121-1
  • Beier K, Eppanapally S, Bazick HS, et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of normal creatinine. Crit Care Med. 2011;39:305–313. doi:10.1097/CCM.0b013e3181ffe22a
  • Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Investigation. 1995;95:39–45. doi:10.1172/JCI117668
  • Chen WJ, Oashi E, Kasai M. Amino acid metabolism in parenteral nutrition: with special reference to the calorie: nitrogen ratio and the blood urea nitrogen level. Metabolism. 1974;23(12):1117–1123. doi:10.1016/0026-0495(74)90028-6
  • Farruggia P, Fioredda F, Puccio G, et al. Idiopathic neutropenia of infancy: data from the Italian Neutropenia Registry. Am J Hematol. 2019;94(2):216–222. doi:10.1002/ajh.25353
  • Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med. 2007;356:904–910. doi:10.1056/NEJMoa065066